M. Mostafi, “The outcome of Daclatasvir and low dose Sofosbuvir therapy in end-stage renal disease patients with hepatitis C virus infection”, Ukr. J. Nephrol. Dial., no. 2(66), pp. 3-8, Apr. 2020.